Zizza, Vincent
Zizza, Vincent was paid $379K by Medicaid between Jan 2018 and Dec 2024, across 16 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoZIZZA, VINCENT
WARWICK, RI 02886
WARWICK, RI 02886
33aNPI1528085289assigned 07/17/2006
33bProvider typeSpecialist
28Total paid$379K
24GClaims7,289
24DCodes billed16
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Rhode Island
Rank by total paid#5 of 46
Median peer was paid$29K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 193 | $5K | |
| 2022 | 146 | $7K | |
| 2023 | 3,535 | $182K | |
| 2024incomplete | 3,415 | $185K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 2,297 | 2,215 | $157K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 24% | 1,106 | 1,088 | $90K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 1,261 | 1,234 | $62K |
| 87428 | 6.5% | 452 | 443 | $25K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.7% | 206 | 193 | $22K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 237 | 232 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 602 | 588 | $6K |
| 71046 | Radiologic examination, chest; 2 views | 1.7% | 356 | 347 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 100 | 49 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 58 | 55 | $823.18 |
| 81003 | <1% | 490 | 479 | $742.62 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 37 | 37 | $591.36 |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.